Professor Dyfrig Hughes
Athro mewn Ffarmacoeconomeg / Cyfarwyddwr Ymchwil
- Papur › Ymchwil › Heb ei adolygu gan gymheiriaid
- Cyhoeddwyd
From efficacy to effectiveness and cost-effectiveness: modelling possibilities
Hughes, D. & Hughes, D. A., 1 Tach 2004.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Health and economic outcomes: Why compliance matters
Hughes, D. & Hughes, D. A., 1 Ebr 2006.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Impact of non-compliance on the clinical and cost-effectiveness of statins
Hughes, D. & Hughes, D. A., 1 Tach 2001.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Impact of non-compliance on the cost-effectiveness of pharmaceuticals
Hughes, D. & Hughes, D. A., 1 Tach 2002.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.
Hughes, D., Hughes, D. A., Al-Zubiedi, S., Hanson, A., Jorgensen, A. & Pirmohamed, M., 1 Ion 2009.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Impact of the abolition of prescription charges in Wales: a multi-level modelling approach with application to time series dispensed rate data
Hughes, D., Alam, F., Myles, S., Hughes, D. A., Dunstan, F., Routledge, P. & Cohen, D., 1 Medi 2007.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Impact of the abolition of the prescription charge in Wales
Hughes, D. & Hughes, D. A., 1 Tach 2008.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Impact of the abolition of the prescription charge in Wales.
Hughes, D., Hughes, D. A., Alam, M. F., Cohen, D., Dunstan, F., Groves, S. & Routledge, P., 1 Ion 2009, t. O41.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Impact of the abolition of the prescription charge in Wales.
Hughes, D., Hughes, D. A., Alam, M. F., Cohen, D., Dunstan, F., Groves, S. & Routledge, P., 1 Ion 2009.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Impact of the abolition of the prescription charge in Wales.
Hughes, D., Hughes, D. A., Alam, M. F., Cohen, D., Dunstan, F., Groves, S. & Routledge, P., 1 Ion 2009.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Incorporating measures of compliance and persistence in pharmacoeconomic evaluations
Hughes, D., Hughes, D. A. & Cowell, W., 1 Tach 2005.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Integrating compliance and persistence in health economics models
Hughes, D. & Hughes, D. A., 1 Ion 2008.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Interventions that enhance medication compliance and persistence: Theoretical grounding, and economic assessment
Hughes, D., Hughes, D. A., Gwadry Sridhar, F., Elliott, R. & Cowell, W., 1 Hyd 2007.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Introduction to pharmaeconomics
Hughes, D. & Hughes, D. A., 1 Gorff 2004.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Investigating factors influencing user choices to visit either general practitioners or community pharmacists in the management of minor ailments
Hughes, D. & Hughes, D. A., 1 Mai 2006.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Investigating factors influencing user choices to visit either general practitioners or community pharmacists in the management of minor ailments - piloting a discrete choice experiment
Hughes, D., Myles, S., Hughes, D. A., Longo, M. & Lisles, C., 1 Meh 2006.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Methodological issues in the literature on costs of non-compliance in chronic diseases
Hughes, D., Salas, M., Zuluaga, A., Hughes, D. A., Cowell, W., Lebmeie, M., Vardeva, K., Pisu, M. & Shinogle, J., 1 Tach 2008.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Modelling changes in first line antimalarial therapy
Hughes, D. & Hughes, D. A., 1 Medi 2003.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Orphan drug treatments: economic considerations
Hughes, D. & Hughes, D. A., 1 Tach 2007.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Patient compliance and persistence with prescribed medication: Measurement and health economic impact
Hughes, D., Koncz, T., Hughes, D. A., Cleemput, I. & Annemans, L., 1 Mai 2004.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Patient compliance and pharmacoeconomics
Hughes, D. & Hughes, D. A., 1 Tach 2002.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Patient compliance and pharmacoeconomics
Hughes, D. & Hughes, D. A., 1 Hyd 2001.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Pharmacoeconomic evaluations in Ireland, Scotland and Wales: A Celtic perspective on pharmaceutical assessment
Hughes, D., Hughes, D. A., Drummond, M., Tolley, K. & Ryan, M., 1 Hyd 2007.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Pharmacoeconomic models that incorporate non-compliance
Hughes, D. & Hughes, D. A., 1 Gorff 2004.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
- Cyhoeddwyd
Pharmacoeconomics appraisals by the all Wales medicines strategy group
Hughes, D. & Hughes, D. A., 1 Gorff 2004.Allbwn ymchwil: Cyfraniad at gynhadledd › Papur